Helicobacter pylori virulence factors in gastric carcinogenesis

Cancer Letters

Volumn 282, Issue 1, 2009, Pages 1-8

  Wen, Sicheng ^a   Moss, Steven F ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

CagA; Gastric cancer; Helicobacter pylori; VacA; Virulence factors

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN CRK; ADHESIN; BLOOD GROUP ANTIGEN BINDING ADHESIN 1; BLOOD GROUP ANTIGEN BINDING ADHESIN 2; CAGA PROTEIN; CAGL PROTEIN; CYTOTOXIN; CYTOTOXIN ASSOCIATED ANTIGEN; DUODENAL ULCER PROMOTING PROTEIN; GENE PRODUCT; INTEGRIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN SH2; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; SIALIC ACID BINDING ADHESIN; UNCLASSIFIED DRUG; UVOMORULIN; VACUOLATING TOXIN;

ANTIGEN BINDING; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CANCER RISK; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CELL MOTILITY; CELL POLARITY; CELL PROLIFERATION; DUODENUM ULCER; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENE TRANSLOCATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; STOMACH CANCER; STOMACH CARCINOGENESIS; T LYMPHOCYTE ACTIVATION;

HELICOBACTER PYLORI;

EID: 67649395627     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.11.016     Document Type: Review

References (96)

1. Talley N.J., Fock K.M., and Moayyedi P. Gastric cancer consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am. J. Gastroenterol. 103 (2008) 510-514
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002 CA. Cancer. J. Clin. 55 (2005) 74-108
3. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18 (2007) 581-592
4. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., and Schlemper R.J. Helicobacter pylori infection and the development of gastric cancer. New Engl. J. Med. 345 (2001) 784-789
5. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer. 118 (2006) 3030-3044
6. Amieva M.R., and El-Omar E.M. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134 (2008) 306-323
7. Forman D., and Burley V.J. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract. Res. Clin. Gastroenterol. 20 (2006) 633-649
8. Linz B., Balloux F., Moodley Y., Manica A., Liu H., Roumagnac P., Falush D., Stamer C., Prugnolle F., van der Merwe S.W., Yamaoka Y., Graham D.Y., Perez-Trallero E., Wadstrom T., Suerbaum S., and Achtman M. An African origin for the intimate association between humans and Helicobacter pylori. Nature 445 (2007) 915-918
9. Lu H., Yamaoka Y., and Graham D.Y. Helicobacter pylori virulence factors: facts and fantasies. Curr. Opin. Gastroenterol. 21 (2005) 653-659
10. Tomb J.F., White O., Kerlavage A.R., Clayton R.A., Sutton G.G., Fleischmann R.D., Ketchum K.A., Klenk H.P., Gill S., Dougherty B.A., Nelson K., Quackenbush J., Zhou L., Kirkness E.F., Peterson S., Loftus B., Richardson D., Dodson R., Khalak H.G., Glodek A., McKenney K., Fitzegerald L.M., Lee N., Adams M.D., Hickey E.K., Berg D.E., Gocayne J.D., Utterback T.R., Peterson J.D., Kelley J.M., Cotton M.D., Weidman J.M., Fujii C., Bowman C., Watthey L., Wallin E., Hayes W.S., Borodovsky M., Karp P.D., Smith H.O., Fraser C.M., and Venter J.C. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388 (1997) 539-547
11. Alm R.A., Ling L.S., Moir D.T., King B.L., Brown E.D., Doig P.C., Smith D.R., Noonan B., Guild B.C., deJonge B.L., Carmel G., Tummino P.J., Caruso A., Uria-Nickelsen M., Mills D.M., Ives C., Gibson R., Merberg D., Mills S.D., Jiang Q., Taylor D.E., Vovis G.F., and Trust T.J. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397 (1999) 176-180
12. Censini S., Lange C., Xiang Z., Crabtree J.E., Ghiara P., Borodovsky M., Rappuoli R., and Covacci A. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93 (1996) 14648-14653
13. Covacci A., Telford J.L., Del Giudice G., Parsonnet J., and Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 284 (1999) 1328-1333
14. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Memet S., Huerre M.R., Coyle A.J., DiStefano P.S., Sansonetti P.J., Labigne A., Bertin J., Philpott D.J., and Ferrero R.L. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5 (2004) 1166-1174
15. Mizushima T., Sugiyama T., Komatsu Y., Ishizuka J., Kato M., and Asaka M. Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J. Clin. Microbiol. 39 (2001) 2463-2465
16. Blaser M.J., Perez-Perez G.I., Kleanthous H., Cover T.L., Peek R.M., Chyou P.H., Stemmermann G.N., and Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55 (1995) 2111-2115
17. Gerhard M., Lehn N., Neumayer N., Boren T., Rad R., Schepp W., Miehlke S., Classen M., and Prinz C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl. Acad. Sci. USA 96 (1999) 12778-12783
18. Parsonnet J., Friedman G.D., Orentreich N., and Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40 (1997) 297-301
19. Hamlet A., Thoreson A.C., Nilsson O., Svennerholm A.M., and Olbe L. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology 116 (1999) 259-268
20. Ogura K., Maeda S., Nakao M., Watanabe T., Tada M., Kyutoku T., Yoshida H., Shiratori Y., and Omata M. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J. Exp. Med. 192 (2000) 1601-1610
21. Franco A.T., Israel D.A., Washington M.K., Krishna U., Fox J.G., Rogers A.B., Neish A.S., Collier-Hyams L., Perez-Perez G.I., Hatakeyama M., Whitehead R., Gaus K., O'Brien D.P., Romero-Gallo J., and Peek Jr. R.M. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl. Acad. Sci. USA 102 (2005) 10646-10651
22. Murata-Kamiya N., Kurashima Y., Teishikata Y., Yamahashi Y., Saito Y., Higashi H., Aburatani H., Akiyama T., Peek Jr. R.M., Azuma T., and Hatakeyama M. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26 (2007) 4617-4626
23. Franco A.T., Johnston E., Krishna U., Yamaoka Y., Israel D.A., Nagy T.A., Wroblewski L.E., Piazuelo M.B., Correa P., and Peek Jr. R.M. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 68 (2008) 379-387
24. Israel D.A., Salama N., Arnold C.N., Moss S.F., Ando T., Wirth H.P., Tham K.T., Camorlinga M., Blaser M.J., Falkow S., and Peek Jr. R.M. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J. Clin. Invest. 107 (2001) 611-620
25. Ohnishi N., Yuasa H., Tanaka S., Sawa H., Miura M., Matsui A., Higashi H., Musashi M., Iwabuchi K., Suzuki M., Yamada G., Azuma T., and Hatakeyama M. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl. Acad. Sci. USA 105 (2008) 1003-1008
26. Couturier M.R., Tasca E., Montecucco C., and Stein M. Interaction with CagF is required for translocation of CagA into the host via the Helicobacter pylori type IV secretion system. Infect. Immun. 74 (2006) 273-281
27. Pattis I., Weiss E., Laugks R., Haas R., and Fischer W. The Helicobacter pylori CagF protein is a type IV secretion chaperone-like molecule that binds close to the C-terminal secretion signal of the CagA effector protein. Microbiology 153 (2007) 2896-2909
28. Kwok T., Zabler D., Urman S., Rohde M., Hartig R., Wessler S., Misselwitz R., Berger J., Sewald N., Konig W., and Backert S. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449 (2007) 862-866
29. Higashi H., Tsutsumi R., Muto S., Sugiyama T., Azuma T., Asaka M., and Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295 (2002) 683-686
30. Selbach M., Moese S., Hauck C.R., Meyer T.F., and Backert S. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem. 277 (2002) 6775-6778
31. Stein M., Bagnoli F., Halenbeck R., Rappuoli R., Fantl W.J., and Covacci A. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. 43 (2002) 971-980
32. Tammer I., Brandt S., Hartig R., Konig W., and Backert S. Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 132 (2007) 1309-1319
33. Poppe M., Feller S.M., Romer G., and Wessler S. Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene 26 (2007) 3462-3472
34. Tsutsumi R., Higashi H., Higuchi M., Okada M., and Hatakeyama M. Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J. Biol. Chem. 278 (2003) 3664-3670
35. Suzuki M., Mimuro H., Suzuki T., Park M., Yamamoto T., and Sasakawa C. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J. Exp. Med. 202 (2005) 1235-1247
36. Tsutsumi R., Takahashi A., Azuma T., Higashi H., and Hatakeyama M. Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol. Cell Biol. 26 (2006) 261-276
37. Higashi H., Nakaya A., Tsutsumi R., Yokoyama K., Fujii Y., Ishikawa S., Higuchi M., Takahashi A., Kurashima Y., Teishikata Y., Tanaka S., Azuma T., and Hatakeyama M. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J. Biol. Chem. 279 (2004) 17205-17216
38. Naito M., Yamazaki T., Tsutsumi R., Higashi H., Onoe K., Yamazaki S., Azuma T., and Hatakeyama M. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 130 (2006) 1181-1190
39. Higashi H., Yokoyama K., Fujii Y., Ren S., Yuasa H., Saadat I., Murata-Kamiya N., Azuma T., and Hatakeyama M. EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J. Biol. Chem. 280 (2005) 23130-23137
40. Higashi H., Tsutsumi R., Fujita A., Yamazaki S., Asaka M., Azuma T., and Hatakeyama M. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. USA 99 (2002) 14428-14433
41. Yamaoka Y., Kodama T., Kashima K., Graham D.Y., and Sepulveda A.R. Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J. Clin. Microbiol. 36 (1998) 2258-2263
42. Basso D., Zambon C.F., Letley D.P., Stranges A., Marchet A., Rhead J.L., Schiavon S., Guariso G., Ceroti M., Nitti D., Rugge M., Plebani M., and Atherton J.C. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135 (2008) 91-99
43. Amieva M.R., Vogelmann R., Covacci A., Tompkins L.S., Nelson W.J., and Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300 (2003) 1430-1434
44. Churin Y., Al-Ghoul L., Kepp O., Meyer T.F., Birchmeier W., and Naumann M. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell. Biol. 161 (2003) 249-255
45. Mimuro H., Suzuki T., Tanaka J., Asahi M., Haas R., and Sasakawa C. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell. 10 (2002) 745-755
46. Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., Lu H., Ohnishi N., Azuma T., Suzuki A., Ohno S., and Hatakeyama M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447 (2007) 330-333
47. Zeaiter Z., Cohen D., Musch A., Bagnoli F., Covacci A., and Stein M. Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/Par1b in CagA-mediated disruption of cellular polarity. Cell Microbiol. 10 (2008) 781-794
48. Bagnoli F., Buti L., Tompkins L., Covacci A., and Amieva M.R. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc. Natl. Acad. Sci. USA 102 (2005) 16339-16344
49. Crabtree J.E., Xiang Z., Lindley I.J., Tompkins D.S., Rappuoli R., and Covacci A. Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J. Clin. Pathol. 48 (1995) 967-969
50. Fischer W., Puls J., Buhrdorf R., Gebert B., Odenbreit S., and Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42 (2001) 1337-1348
51. Brandt S., Kwok T., Hartig R., Konig W., and Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl. Acad. Sci. USA 102 (2005) 9300-9305
52. Yokoyama K., Higashi H., Ishikawa S., Fujii Y., Kondo S., Kato H., Azuma T., Wada A., Hirayama T., Aburatani H., and Hatakeyama M. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc. Natl. Acad. Sci. U S A 102 (2005) 9661-9666
53. Telford J.L., Ghiara P., Dell'Orco M., Comanducci M., Burroni D., Bugnoli M., Tecce M.F., Censini S., Covacci A., Xiang Z., et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 179 (1994) 1653-1658
54. Cover T.L., and Blaser M.J. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 267 (1992) 10570-10575
55. Ilver D., Barone S., Mercati D., Lupetti P., and Telford J.L. Helicobacter pylori toxin VacA is transferred to host cells via a novel contact-dependent mechanism. Cell Microbiol. 6 (2004) 167-174
56. Cover T.L., and Blanke S.R. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 3 (2005) 320-332
57. Atherton J.C., Cao P., Peek Jr. R.M., Tummuru M.K., Blaser M.J., and Cover T.L. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270 (1995) 17771-17777
58. McClain M.S., Cao P., Iwamoto H., Vinion-Dubiel A.D., Szabo G., Shao Z., and Cover T.L. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J. Bacteriol. 183 (2001) 6499-6508
59. Pagliaccia C., de Bernard M., Lupetti P., Ji X., Burroni D., Cover T.L., Papini E., Rappuoli R., Telford J.L., and Reyrat J.M. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc. Natl. Acad. Sci. USA 95 (1998) 10212-10217
60. Ji X., Fernandez T., Burroni D., Pagliaccia C., Atherton J.C., Reyrat J.M., Rappuoli R., and Telford J.L. Cell specificity of Helicobacter pylori cytotoxin is determined by a short region in the polymorphic midregion. Infect. Immun. 68 (2000) 3754-3757
61. Atherton J.C., Peek Jr. R.M., Tham K.T., Cover T.L., and Blaser M.J. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112 (1997) 92-99
62. Miehlke S., Kirsch C., Agha-Amiri K., Gunther T., Lehn N., Malfertheiner P., Stolte M., Ehninger G., and Bayerdorffer E. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer 87 (2000) 322-327
63. Rhead J.L., Letley D.P., Mohammadi M., Hussein N., Mohagheghi M.A., Eshagh Hosseini M., and Atherton J.C. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133 (2007) 926-936
64. Ogiwara H., Graham D.Y., and Yamaoka Y. VacA i-region subtyping. Gastroenterology 134 (2008) 1267 (author reply 1268)
65. Leunk R.D., Johnson P.T., David B.C., Kraft W.G., and Morgan D.R. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol. 26 (1988) 93-99
66. Papini E., de Bernard M., Milia E., Bugnoli M., Zerial M., Rappuoli R., and Montecucco C. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc. Natl. Acad. Sci. U S A 91 (1994) 9720-9724
67. Papini E., Satin B., Norais N., de Bernard M., Telford J.L., Rappuoli R., and Montecucco C. Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J. Clin. Invest. 102 (1998) 813-820
68. Galmiche A., Rassow J., Doye A., Cagnol S., Chambard J.C., Contamin S., de Thillot V., Just I., Ricci V., Solcia E., Van Obberghen E., and Boquet P. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. Embo. J. 19 (2000) 6361-6370
69. Cover T.L., Krishna U.S., Israel D.A., and Peek Jr. R.M. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res. 63 (2003) 951-957
70. Manente L., Perna A., Buommino E., Altucci L., Lucariello A., Citro G., Baldi A., Iaquinto G., Tufano M.A., and De Luca A. The Helicobacter pylori 's protein VacA has direct effects on the regulation of cell cycle and apoptosis in gastric epithelial cells. J. Cell Physiol. 214 (2008) 582-587
71. Molinari M., Salio M., Galli C., Norais N., Rappuoli R., Lanzavecchia A., and Montecucco C. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187 (1998) 135-140
72. Allen L.A., Schlesinger L.S., and Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J. Exp. Med. 191 (2000) 115-128
73. Zheng P.Y., and Jones N.L. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol. 5 (2003) 25-40
74. Gebert B., Fischer W., Weiss E., Hoffmann R., and Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301 (2003) 1099-1102
75. Sundrud M.S., Torres V.J., Unutmaz D., and Cover T.L. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Natl. Acad. Sci. USA 101 (2004) 7727-7732
76. Torres V.J., VanCompernolle S.E., Sundrud M.S., Unutmaz D., and Cover T.L. Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J. Immunol. 179 (2007) 5433-5440
77. Sewald X., Gebert-Vogl B., Prassl S., Barwig I., Weiss E., Fabbri M., Osicka R., Schiemann M., Busch D.H., Semmrich M., Holzmann B., Sebo P., and Haas R. Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. Cell Host Microbe 3 (2008) 20-29
78. Boren T., Falk P., Roth K.A., Larson G., and Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262 (1993) 1892-1895
79. Aspholm-Hurtig M., Dailide G., Lahmann M., Kalia A., Ilver D., Roche N., Vikstrom S., Sjostrom R., Linden S., Backstrom A., Lundberg C., Arnqvist A., Mahdavi J., Nilsson U.J., Velapatino B., Gilman R.H., Gerhard M., Alarcon T., Lopez-Brea M., Nakazawa T., Fox J.G., Correa P., Dominguez-Bello M.G., Perez-Perez G.I., Blaser M.J., Normark S., Carlstedt I., Oscarson S., Teneberg S., Berg D.E., and Boren T. Functional adaptation of BabA the H. pylori ABO blood group antigen binding adhesin. Science 305 (2004) 519-522
80. Mahdavi J., Sonden B., Hurtig M., Olfat F.O., Forsberg L., Roche N., Angstrom J., Larsson T., Teneberg S., Karlsson K.A., Altraja S., Wadstrom T., Kersulyte D., Berg D.E., Dubois A., Petersson C., Magnusson K.E., Norberg T., Lindh F., Lundskog B.B., Arnqvist A., Hammarstrom L., and Boren T. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297 (2002) 573-578
81. Ilver D., Arnqvist A., Ogren J., Frick I.M., Kersulyte D., Incecik E.T., Berg D.E., Covacci A., Engstrand L., and Boren T. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279 (1998) 373-377
82. Boren T., Normark S., and Falk P. Helicobacter pylori: molecular basis for host recognition and bacterial adherence. Trends Microbiol. 2 (1994) 221-228
83. Colbeck J.C., Hansen L.M., Fong J.M., and Solnick J.V. Genotypic profile of the outer membrane proteins BabA and BabB in clinical isolates of Helicobacter pylori. Infect. Immun. 74 (2006) 4375-4378
84. Solnick J.V., Hansen L.M., Salama N.R., Boonjakuakul J.K., and Syvanen M. Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proc. Natl. Acad. Sci. USA 101 (2004) 2106-2111
85. Backstrom A., Lundberg C., Kersulyte D., Berg D.E., Boren T., and Arnqvist A. Metastability of Helicobacter pylori bab adhesin genes and dynamics in Lewis b antigen binding. Proc. Natl. Acad. Sci. USA 101 (2004) 16923-16928
86. Prinz C., Schoniger M., Rad R., Becker I., Keiditsch E., Wagenpfeil S., Classen M., Rosch T., Schepp W., and Gerhard M. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res. 61 (2001) 1903-1909
87. Rad R., Gerhard M., Lang R., Schoniger M., Rosch T., Schepp W., Becker I., Wagner H., and Prinz C. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J. Immunol. 168 (2002) 3033-3041
88. Unemo M., Aspholm-Hurtig M., Ilver D., Bergstrom J., Boren T., Danielsson D., and Teneberg S. The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils. J. Biol. Chem. 280 (2005) 15390-15397
89. Aspholm M., Olfat F.O., Norden J., Sonden B., Lundberg C., Sjostrom R., Altraja S., Odenbreit S., Haas R., Wadstrom T., Engstrand L., Semino-Mora C., Liu H., Dubois A., Teneberg S., Arnqvist A., and Boren T. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog. 2 (2006) e110
90. Lu H., Hsu P.I., Graham D.Y., and Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128 (2005) 833-848
91. Hansson L.E., Nyren O., Hsing A.W., Bergstrom R., Josefsson S., Chow W.H., Fraumeni Jr. J.F., and Adami H.O. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. New Engl. J. Med. 335 (1996) 242-249
92. Pan Z.J., van der Hulst R.W., Feller M., Xiao S.D., Tytgat G.N., Dankert J., and van der Ende A. Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J. Clin. Microbiol. 35 (1997) 1344-1347
93. Azuma T., Yamazaki S., Yamakawa A., Ohtani M., Muramatsu A., Suto H., Ito Y., Dojo M., Yamazaki Y., Kuriyama M., Keida Y., Higashi H., and Hatakeyama M. Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J. Infect. Dis. 189 (2004) 820-827
94. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni Jr. J.F., and Rabkin C.S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
95. Machado J.C., Pharoah P., Sousa S., Carvalho R., Oliveira C., Figueiredo C., Amorim A., Seruca R., Caldas C., Carneiro F., and Sobrinho-Simoes M. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121 (2001) 823-829
96. Kamangar F., Cheng C., Abnet C.C., and Rabkin C.S. Interleukin-1B polymorphisms and gastric cancer risk - a meta-analysis. Cancer Epidemol. Biomarkers Prev. 15 (2006) 1920-1928